Part of the Oncology Commons
TRACKING TREATMENT RESPONSE AND RESISTANCE TO PARP INHIBITION (TALAZOPARIB) IN HEREDITARY PANCREATIC CANCER., Jennifer Goldstein Dissertations and Theses (Open Access)
PDF
Advanced Search
